BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 721057)

  • 21. [Treatment of the hypertensive crisis by blocking the renin-angiotensin system (author's transl)].
    Wambach G; Kaufmann W
    MMW Munch Med Wochenschr; 1982 Jul; 124(27):638-40. PubMed ID: 6810156
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of renin in the hypertensive patient.
    Brunner HR; Gavras H
    JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
    [No Abstract]   [Full Text] [Related]  

  • 25. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of the saralasin test to the treatment of malignant or accelerated arterial hypertension (author's transl)].
    Bonnet F; Corvol P; Thibonnier M; Reach G; Lardoux MD; Milliez P
    Nouv Presse Med; 1980 Nov; 9(41):3075-8. PubMed ID: 7443447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F; Messore T; Catzola A; Corvino A; Genovese A; Catalano M; Mercone G
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract]   [Full Text] [Related]  

  • 28. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 29. The renin system in essential, renovascular and adrenocortical hypertension: an overview.
    Laragh JH
    Adv Nephrol Necker Hosp; 1977; 7():157-89. PubMed ID: 96672
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhibition of the renin-angiotensin system in treating arterial hypertension].
    Fagard R; Leuven KU; Staessen J; Amery A
    Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041
    [No Abstract]   [Full Text] [Related]  

  • 31. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Saralasin in the diagnosis of angiotensin-dependent hypertension and in the study of the renin-angiotensin-aldosterone system].
    Falch D
    Tidsskr Nor Laegeforen; 1983 Apr; 103(11):906-8. PubMed ID: 6879526
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
    Kabat M; Makowiecka-Cieśla M
    Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092
    [No Abstract]   [Full Text] [Related]  

  • 35. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ; Baer L; Radichevich I
    Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
    [No Abstract]   [Full Text] [Related]  

  • 36. Saralasin testing for renin-dependent hypertension.
    Weber MA
    Arch Intern Med; 1979 Jan; 139(1):93-5. PubMed ID: 760691
    [No Abstract]   [Full Text] [Related]  

  • 37. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic relevancy of saralasin in renin-dependent hypertension].
    Röckel A; Wernze H; Spech HJ; Scheitza E; Hennemann H; Heidland A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1307-10. PubMed ID: 1029985
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.